[18F]PSMA-1007 PET/CT影像组学可能有助于提高激素敏感性前列腺癌患者骨局灶性摄取的解释
本研究回顾性分析102例激素敏感性前列腺癌患者的[18F]PSMA-1007 PET/CT图像,共178个骨局灶性摄取,以临床随访为标准,74个(41.5%)为转移灶。影像组学模型联合PET与CT特征的准确率为84.69%,但未超过专家PET阅片者;低经验阅片者基线诊断准确率显著较低(p<0.05),加入影像组学评分后提高(与第一轮相比p<0.05)。结论认为影像组学可能有助于区分骨转移与非特异性骨摄取。
要点
- 在178个[18F]PSMA-1007骨局灶性摄取中,74个(41.5%)经参考标准判定为前列腺癌转移。
- 影像组学模型(PET+CT特征)准确率为84.69%,但两个轮次均未超过专家PET阅片者。
- 低经验阅片者基线诊断准确率显著较低(p<0.05),加入影像组学评分后提高(与第一轮相比p<0.05)。
核心结论
- 影像组学可能有助于鉴别骨转移与非特异性骨摄取,但未超过专家视觉评估。
- 影像组学有潜力提高低经验阅片者评估[18F]PSMA-1007 PET/CT骨摄取的诊断准确率。
研究设计与样本
- 回顾性分析102例接受[18F]PSMA-1007 PET/CT的激素敏感性前列腺癌患者,均有至少一个骨局灶性摄取及已知临床随访(参考标准)。
- 使用matRadiomics提取每个骨摄取的PET与CT影像特征,采用机器学习方法构建骨转移最佳预测模型并生成影像组学评分。
- 低经验(n=2)与高经验(n=2)PET阅片者在盲法下将每个骨摄取评为非特异性骨摄取或骨转移。
- 同一批阅片者三个月后进行第二轮阅片,并可获取影像组学评分。
主要发现
- 178个[18F]PSMA-1007骨摄取中,74个(41.5%)被参考标准分类为前列腺癌转移。
- 联合PET与CT特征的影像组学模型准确率为84.69%,但在两个轮次中均未超过专家PET阅片者。
- 低经验阅片者基线诊断准确率显著较低(p<0.05)。
- 低经验阅片者加入影像组学评分后诊断准确率提高(与第一轮相比p<0.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We hypothesised that applying radiomics to [18F]PSMA-1007 PET/CT images could help distinguish Unspecific Bone Uptakes (UBUs) from bone metastases in prostate cancer (PCa) patients. We compared the performance of radiomic features to human visual interpretation. MATERIALS AND METHODS: We retrospectively analysed 102 hormone-sensitive PCa patients who underwent [18F]PSMA-1007 PET/CT and exhibited at least one focal bone uptake with known clinical follow-up (reference standard). Using matRadiomics, we extracted features from PET and CT images of each bone uptake and identified the best predictor model for bone metastases using a machine-learning approach to generate a radiomic score. Blinded PET readers with low (n = 2) and high (n = 2) experience rated each bone uptake as either UBU or bone metastasis. The same readers performed a second read three months later, with access to the radiomic score. RESULTS: Of the 178 [18F]PSMA-1007 bone uptakes, 74 (41.5%) were classified as PCa metastases by the reference standard. A radiomic model combining PET and CT features achieved an accuracy of 84.69%, though it did not surpass expert PET readers in either round. Less-experienced readers had significantly lower diagnostic accuracy at baseline (p < 0.05) but improved with the addition of radiomic scores (p < 0.05 compared to the first round). CONCLUSION: Radiomics might help to differentiate bone metastases from UBUs. While it did not exceed expert visual assessments, radiomics has the potential to enhance the diagnostic accuracy of less-experienced readers in evaluating [18F]PSMA-1007 PET/CT bone uptakes.
引用
- Bauckneht M, Pasini G, Di Raimondo T, et al. [18F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients. Eur J Nucl Med Mol Imaging. 2025. PMID: 39873702. doi:10.1007/s00259-025-07085-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。